MX2013000201A - Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento. - Google Patents

Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento.

Info

Publication number
MX2013000201A
MX2013000201A MX2013000201A MX2013000201A MX2013000201A MX 2013000201 A MX2013000201 A MX 2013000201A MX 2013000201 A MX2013000201 A MX 2013000201A MX 2013000201 A MX2013000201 A MX 2013000201A MX 2013000201 A MX2013000201 A MX 2013000201A
Authority
MX
Mexico
Prior art keywords
health care
delivering
filament
methods
administering
Prior art date
Application number
MX2013000201A
Other languages
English (en)
Inventor
Gregory Charles Gordon
William Maxwell Allen Jr
Rajeev Chhabra
Trevor John Darcy
Steven Ray Gilbert
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2013000201A publication Critical patent/MX2013000201A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D4/00—Spinnerette packs; Cleaning thereof
    • D01D4/02—Spinnerettes
    • D01D4/025—Melt-blowing or solution-blowing dies
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/08—Melt spinning methods
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
    • D04H3/08—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating
    • D04H3/16—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating with bonds between thermoplastic filaments produced in association with filament formation, e.g. immediately following extrusion

Abstract

Un método para suministrar un activo de atención sanitaria que tiene los pasos de administrar a un mamífero que necesite un beneficio de salud o un tratamiento para una afección médica un artículo de cuidado personal y consumir el artículo. El artículo contiene uno o más filamentos que comprenden un material principal, un activo para el cuidado de la salud y, opcionalmente, agentes estéticos, auxiliares de extensión, plastificantes y agentes de reticulación.
MX2013000201A 2010-07-02 2011-06-30 Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento. MX2013000201A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US36115410P 2010-07-02 2010-07-02
US36112610P 2010-07-02 2010-07-02
US36113510P 2010-07-02 2010-07-02
US36098210P 2010-07-02 2010-07-02
US36115910P 2010-07-02 2010-07-02
US36112910P 2010-07-02 2010-07-02
US36114610P 2010-07-02 2010-07-02
PCT/US2011/042641 WO2012003350A1 (en) 2010-07-02 2011-06-30 Methods of delivering a health care active by administering personal health care articles comprising a filament

Publications (1)

Publication Number Publication Date
MX2013000201A true MX2013000201A (es) 2013-08-21

Family

ID=45402453

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000201A MX2013000201A (es) 2010-07-02 2011-06-30 Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento.

Country Status (10)

Country Link
US (5) US20120172831A1 (es)
EP (1) EP2588091B1 (es)
CN (1) CN102970987A (es)
AU (1) AU2011272839B2 (es)
CA (1) CA2803377C (es)
ES (1) ES2792800T3 (es)
MX (1) MX2013000201A (es)
PL (1) PL2588091T3 (es)
RU (2) RU2613316C1 (es)
WO (1) WO2012003350A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012003350A1 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
BR112012033600A2 (pt) 2010-07-02 2016-11-29 Procter & Gamble Comapny filamentos compreendendo mantas de não-tecido com agente ingerível e métodos de fabricação dos mesmos.
EP2588654B1 (en) 2010-07-02 2019-08-07 The Procter and Gamble Company Nonwoven web comprising one or more active agents
WO2012003319A2 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
JP5759544B2 (ja) 2010-07-02 2015-08-05 ザ プロクター アンド ギャンブルカンパニー 活性剤を送達する方法
CA2803371C (en) 2010-07-02 2016-04-19 The Procter & Gamble Company Process for making films from nonwoven webs
BR112013020816A2 (pt) * 2011-03-01 2016-10-18 Procter & Gamble substrato sólido poroso desintegrável para aplicações para cuidados pessoais com a saúde
JP6077711B2 (ja) * 2013-03-15 2017-02-08 ザ プロクター アンド ギャンブル カンパニー 溶解性繊維を含むパーソナルケア物品
CN103232618B (zh) * 2013-05-14 2015-04-22 青岛科凯达橡塑有限公司 一种可降解材料及其制备方法
CN103224649B (zh) * 2013-05-14 2015-04-22 青岛科凯达橡塑有限公司 一种可降解材料及其制备方法
US10849940B2 (en) 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
CN103924314A (zh) * 2014-04-25 2014-07-16 邓振平 一种用于治疗艾滋病及并发症的药布
KR101675064B1 (ko) * 2014-11-24 2016-11-10 포항공과대학교 산학협력단 복합추출물을 함유하는 운동수행능력 증강 및 체력증진용 조성물
WO2017058175A1 (en) 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN105463702B (zh) * 2015-12-30 2018-03-20 闽江学院 一种含蜂胶的静电复合纺纳米纤维膜及其生产方法
CN105442181B (zh) * 2015-12-30 2018-01-09 闽江学院 一种蜂胶静电纺纳米纤维膜及其生产方法
US10773405B2 (en) * 2016-06-30 2020-09-15 The Gillette Company Llc Shaving aid for razor cartridges comprising a nano-filament comprising a core and sheath
CN110167639B (zh) 2017-01-27 2022-10-14 宝洁公司 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物
JP7110356B2 (ja) 2018-01-26 2022-08-01 ザ プロクター アンド ギャンブル カンパニー 香料を含む水溶性単位用量物品
KR102433420B1 (ko) 2018-01-26 2022-08-18 더 프록터 앤드 갬블 캄파니 수용성 물품 및 관련 방법
CN111556891B (zh) 2018-01-26 2021-11-05 宝洁公司 包含酶的水溶性单位剂量制品
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions
CN112135783A (zh) * 2018-05-14 2020-12-25 宝洁公司 洁牙剂分配器
JP2021523142A (ja) 2018-05-14 2021-09-02 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 単位用量口腔ケア組成物
WO2020009940A1 (en) * 2018-07-06 2020-01-09 The Regents Of The University Of California Parallel-additive manufacturing of objects made of aqueous and/or organic materials
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
US11859338B2 (en) 2019-01-28 2024-01-02 The Procter & Gamble Company Recyclable, renewable, or biodegradable package
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
JP7431510B2 (ja) * 2019-04-15 2024-02-15 株式会社リブドゥコーポレーション 吸収性物品
EP3980962A1 (en) 2019-06-10 2022-04-13 The Procter & Gamble Company Method of generating user feedback information to enhance product use results
WO2020252501A1 (en) 2019-06-13 2020-12-17 The Procter & Gamble Company Kits comprising unit-dose oral care compositions
MX2021013141A (es) 2019-06-28 2021-12-10 Procter & Gamble Articulos fibrosos solidos disolubles que contienen surfactantes anionicos.
US11925698B2 (en) 2020-07-31 2024-03-12 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
US11464384B1 (en) 2022-03-31 2022-10-11 Techtronic Cordless Gp Water soluable package for a floor cleaner
CN114575036B (zh) * 2022-04-06 2023-07-21 江苏科溪蔓生物科技有限公司 一种松针基长效抑菌、全降解熔喷布及其制备方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723134A (en) 1968-05-17 1973-03-27 Gen Mills Inc Process for making candy floss
US3849241A (en) * 1968-12-23 1974-11-19 Exxon Research Engineering Co Non-woven mats by melt blowing
IT1008202B (it) 1974-07-31 1976-11-10 Lostia Onofrio Fibre inglobanti anticorpi antige ni antisieri procedimento per la loro preparazione e loro impieghi
US4349531A (en) 1975-12-15 1982-09-14 Hoffmann-La Roche Inc. Novel dosage form
US4180558A (en) 1978-08-21 1979-12-25 Hoffmann-La Roche Inc. Unit dosage forms
US5034421A (en) 1988-12-13 1991-07-23 Fuisz Pharmaceutical Ltd. Moderated spun fibrous system and method of manufacture
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH0340879A (ja) 1989-07-07 1991-02-21 Kuraray Co Ltd 薬効性繊維及びその製造方法
JPH03101618A (ja) 1989-09-13 1991-04-26 Kuraray Co Ltd 薬効性繊維及びその製造法
WO1992006603A1 (en) 1990-10-10 1992-04-30 Fuisz Technologies Ltd. Taste masked medicated floss
DE69222847T3 (de) 1991-04-16 2005-09-15 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung einer festen dispersion
PL170554B1 (pl) 1991-12-17 1996-12-31 Fuisz Technologies Ltd Sposób wytwarzania kompozycji przeciwwrzodowej PL PL PL
JP3040879B2 (ja) 1992-05-27 2000-05-15 株式会社奥村組 建築材料の吸音率の測定方法および測定装置
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5520924A (en) 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
GB9414305D0 (en) * 1994-07-15 1994-09-07 C V Lab Ltd Alginate fibre, process for the preparation thereof and use
US5705183A (en) 1994-11-16 1998-01-06 Phillips Company Cotton candy coated medication and a method for making and administering the same
US5681724A (en) 1995-11-16 1997-10-28 Heska Corporation Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
US6165217A (en) * 1997-10-02 2000-12-26 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
CA2246031C (en) * 1998-08-28 2003-08-05 Norman Dust Boat
WO2000013680A2 (en) 1998-09-09 2000-03-16 Quadrant Holdings Cambridge Limited Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
DE19856668A1 (de) * 1998-12-09 2000-06-15 Aesculap Ag & Co Kg Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung
HUP0201620A3 (en) * 1999-07-02 2003-02-28 Procter & Gamble Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
EP1090928B1 (en) 1999-09-30 2004-05-26 Chienna B.V. Polymers loaded with bioactive agents
AU6132700A (en) 1999-09-30 2001-04-05 Chienna B.V. Polymers loaded with bioactive agents
EP1120109A3 (en) 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
JP2003521493A (ja) * 2000-01-28 2003-07-15 スミスクライン・ビーチャム・コーポレイション 電気紡糸された医薬組成物
AU2002249852A1 (en) 2000-11-09 2002-08-12 Board Of Trustees Of The University Of Illinois Enhancement of immune response to vaccine by interferon alpha
EP1372604A2 (en) 2001-03-22 2004-01-02 Battelle Memorial Institute Manufacturing dissolvable dosage forms
US20060189526A1 (en) 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US7491407B2 (en) 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
US20030017208A1 (en) 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
US20060083784A1 (en) 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
US7662257B2 (en) * 2005-04-21 2010-02-16 Georgia-Pacific Consumer Products Llc Multi-ply paper towel with absorbent core
MX296137B (es) * 2003-06-30 2012-02-13 Procter & Gamble Tramas de nanofibras recubiertas.
US20050136112A1 (en) 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US7856989B2 (en) 2004-12-30 2010-12-28 Philip Morris Usa Inc. Electrostatically produced fast dissolving fibers
WO2006106514A2 (en) 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US20100303881A1 (en) 2006-02-02 2010-12-02 The John Hopkins University Therapeutic Electrospun Fiber Compositions
US20080220054A1 (en) 2006-10-13 2008-09-11 Shastri V Prasad Modulation of drug release rate from electrospun fibers
ATE521375T1 (de) 2006-10-23 2011-09-15 Eth Zuerich Implantatmaterial
EP2079416A4 (en) 2006-10-30 2012-06-27 Univ Rutgers ELECTROSPIN MATRICES FOR DISPENSING HYDROPHILIC AND LIPOPHILLE COMPOUNDS
DE102007011606A1 (de) * 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege
US20100018641A1 (en) * 2007-06-08 2010-01-28 Kimberly-Clark Worldwide, Inc. Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers
KR100937625B1 (ko) * 2007-08-10 2010-01-20 주식회사 제닉 가용성 웹 공극필름 및 이의 제조방법
US8974814B2 (en) 2007-11-12 2015-03-10 California Institute Of Technology Layered drug delivery polymer monofilament fibers
CN101946033B (zh) 2007-12-28 2012-11-28 3M创新有限公司 复合非织造纤维料片及其制备和使用方法
EP2323635A2 (de) 2008-08-08 2011-05-25 Basf Se Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung
CA2769636A1 (en) 2009-07-30 2011-02-03 The Procter & Gamble Company Oral care articles and methods
US7900713B2 (en) 2009-08-07 2011-03-08 Top Gearbox Industry Co., Ltd. Main shaft locking mechanism
WO2012003350A1 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament

Also Published As

Publication number Publication date
CA2803377A1 (en) 2012-01-05
CN102970987A (zh) 2013-03-13
RU2535040C2 (ru) 2014-12-10
RU2613316C1 (ru) 2017-03-15
US20130253017A1 (en) 2013-09-26
EP2588091A1 (en) 2013-05-08
AU2011272839A1 (en) 2013-01-17
US10517836B2 (en) 2019-12-31
US20120172831A1 (en) 2012-07-05
US9801830B2 (en) 2017-10-31
EP2588091B1 (en) 2020-04-15
US10912738B2 (en) 2021-02-09
CA2803377C (en) 2018-03-20
US20210154150A1 (en) 2021-05-27
ES2792800T3 (es) 2020-11-12
RU2012158241A (ru) 2014-08-10
US20200060984A1 (en) 2020-02-27
PL2588091T3 (pl) 2020-08-24
US20180015048A1 (en) 2018-01-18
US10449163B2 (en) 2019-10-22
AU2011272839B2 (en) 2015-04-02
US20180289628A1 (en) 2018-10-11
WO2012003350A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
MX2013000201A (es) Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento.
EA201170465A1 (ru) Способы лечения прогрессирующего множественного склероза
CY1117419T1 (el) Εναιωρημα βλαστοκυτταρου
MX2015010312A (es) Metodos para tratamiento del melanoma.
MX2015000582A (es) Capsula de fragancia de hidrogel, formulaciones y proceso para preparar la misma.
IN2012DN02325A (es)
MX2013012253A (es) Conjugados novedosos de aglutinante-farmaco (adc) y su uso.
MX336139B (es) Dispositivos medicos para la entrega de arn de interferencia corta.
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
MX2014000129A (es) Combinaciones de farmacos y su usos en el tratamiento de una condicion de tos.
MX2013004061A (es) Analogos de ciclosporina.
CA144834S (en) Oral care implement package
PE20131065A1 (es) Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascular
MX2013004062A (es) Analogos de ciclosporina.
CA144308S (en) Bottle
GB201201753D0 (en) Therapeutic agents with improved fibrinogen binding
PL2753182T3 (pl) Środki czynne przeciw szczepom Pseudomonas powodującym choroby gnilne w uprawach grzybów, ich zastosowanie i zawierające je kompozycje
GB2490854A (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
SG178967A1 (en) Antimicrobial compositions and products
EP2578232A4 (en) TREATMENT FOR AUTOIMMUN DISEASES AND ALLERGIC DISEASES
GB201115977D0 (en) Neurodevelopmental disorders
EP2623119A4 (en) GLIOMETRY PROCESS, GLIOMETER EXAMINATION METHOD, METHOD FOR DELIVERING A SOLVENT MATERIAL TO A GLIOM AND MEDICAMENT USED IN THESE PROCEDURES
MX351765B (es) Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares.
IT1401401B1 (it) Lega per articoli di oreficeria, gioielleria e simili e prodotti ottenuti con tale lega.

Legal Events

Date Code Title Description
FG Grant or registration